Navigation Links
Study Reveals Impact Of Health Insurance On Hispanics' Attitudes Towards Healthcare Providers
Date:2/2/2010

Language preference is a strong indicator of satisfaction with customer service and claims management.

Miami, FL (Vocus) February 1, 2010 -- Geoscape published its most recent study that reveals a multi-dimensional view of Hispanic purchase behavior and usage of healthcare & medical insurance. The BehaviorBase™ Healthcare study reflects views and beliefs based on a survey of 2,219 Hispanic households of varying demographic and sociographic backgrounds nationwide. Advanced sampling and data collecting methods were used to reveal findings on market share, marketing, strategy, business development and advertising.

An insight revealed by the study is that among insured Hispanics, close to one-third have immediate family members without insurance coverage. Nine percent of those surveyed claimed to have switched health insurance carriers within the last 1-2 years due to a change in job situation or a change in employers. This rate of attrition is expected to increase to 10.2% due to rising health care costs.

“These findings figure prominently into how policy-makers, medical and public health institutions connect with the needs of Hispanic families, especially now, during the peak of healthcare reform and consideration of the United States National Health Care Program,” according to César M Melgoza, Founder & CEO of Geoscape, the publisher of the study.

“We believe it's important as the state's largest health insurer to understand the needs and preferences among different segments of the Latino population in order to develop products and services that meet their needs,” said Pamela Garanger, Primary Research Manager of Horizon Blue Cross and Blue Shield of New Jersey.

An executive summary of the database is available at http://www.geoscape.com/healthcare and the full report and database are available online by subscription. BehaviorBase™ HealthCare is available from national and state view level within the Geoscape Intelligence System (GIS) which offers a suite of databases and analytic modules within an online software-as-service platform.

About Geoscape

Geoscape serves its clients by providing business strategy, research, analytics, databases and automated intelligence systems. The online Geoscape Intelligence System (GIS), the DirecTarget® database enrichment system and a variety of geo-demographic, consumer, business and media databases enable actionable insights that lead our clients to gain significant business advantages. Geoscape is pleased to have served most of the Fortune 500 corporations over the last several years. Geoscape is a privately held company based in Miami and owned by Goldman Sachs, Inc. and César M Melgoza, Founder & CEO.


Press Contact:

Jenna Stone or Alaina Smith at 1-888-211-9353; www.geoscape.com

###

Read the full story at http://www.prweb.com/releases/Geoscape/health_insurance/prweb3549764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Flawed Autism Study Retracted by Medical Journal
2. Adam Slone to Present the 2010 Study on Executive Compensation Benefits for the Diagnostic Laboratory Industry
3. Fish Oil Helped Stave Off Psychosis in Study Patients
4. Study: Many physicians not using established criteria
5. A Study by Celibre Medical Corporation Shows Botox Injections to be the Most Desirable Cosmetic Procedure in Southern California
6. Study Suggests High HIV Rate Among African Teens
7. New study shows effectiveness of MEND program in prevention and treatment of pediatric obesity
8. FRC Responds to New Study Showing Abstinence Education is Most Effective
9. Abstinence-Only Classes Reduced Sexual Activity, Study Found
10. Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery
11. Halt Uterine Fibroid Study Attracts National Media Attention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... its market value in 2016. There are currently three proton therapy centers ... to treat more patients. In Italy , the first ...
(Date:3/29/2017)... 2017  Providence Medical Technology, Inc., an innovator ... two industry veterans to the commercial leadership team.  ... to lead Global Marketing, and Michael Scott ... and Mr. Scott have over 40 years of ... joins the company with over 22 years of ...
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
Breaking Medicine Technology: